In this regard, a very recent paper [37], has found that TMPRSS2-ERG rearrangement and PTEN loss are frequently found in association with heterogeneous loss of DNA repair factors and this has been suggested to reveal an unconventional DNA damage checkpoint regulation mechanism in prostate carcinogenesis, that could have applications in new targeted therapy strategies in this tumor. This evidence concerns the gene TMPRSS2 and neoplasm.